Phenylephrine Hydrochloride Injection, Solution
Product Images NDC 25021-315

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenylephrine Hydrochloride (NDC 25021-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Phe0f 0000 01)

Structural Formula (Phe0f 0000 01)
Chemical structure of Phenylephrine Hydrochloride, showing the molecular arrangement including a benzene ring with hydroxyl groups and the hydrochloride salt.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Phe0f 0000 02)

Package Label – Principal Display Panel – Vial Label (Phe0f 0000 02)
Label for Phenylephrine Hydrochloride Injection, USP 10 mg per mL, an intravenous solution by Sagent Pharmaceuticals. The label includes the NDC 25021-315-01, directions noting that it must be diluted and protected from light, and indicates it is for a 1 mL single-dose vial. Manufactured in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.